Endo Pharmaceuticals Provides Regulatory Update On AVEED(TM) (Testosterone Undecanoate) Injection
08:40AM 12/03/09
Penwest Reports 3Q Profit, Cost Cutting Plans
Penwest Pharmaceuticals reports 3rd-quarter profit, plans to cut staff, consolidate facilities
10:17AM 11/05/09
Endo 3Q Profit Falls On Indevus Buyout Costs
Endo Pharmaceuticals' 3rd-quarter profit dips on buyout costs; pain drugs drive revenue
08:07AM 10/29/09
Endo Rises On Analyst Upgrade And Profit Estimates
Endo Pharma upgraded before FDA ruling on Fortesta; analyst says profits will top views
12:22PM 10/05/09
Morning Playbook: Dividend.com
Brocade is strong on news that it may have put itself up for sale.
09:24AM 10/05/09
Morning Playbook: Dividend.com
The employment report will influence today's trade.
09:11AM 10/02/09
Don't Fret Over Allos Weakness: BioBuzz
Lymphoma drug will be approved and used
02:43PM 09/03/09
FDA Extends Review Of Endo Drug By 3 Months
Endo Pharma says FDA extends review of testosterone injection to Dec. 2, from Sept. 2
04:48PM 09/02/09
FDA Panel Rejects Vion Leukemia Drug
Concerned about safety, panel asks for another trial to be conducted
04:35PM 09/01/09
Endo Buys Testosterone Product For Up To $210M
Endo Pharma says it will pay up to $210M for ProStrakan's testosterone replacement Fortesta
10:42AM 08/26/09
Three Sectors for the Downturn
Health care, international ETFs and pharmaceuticals are three promising venues where buying interest remains strong.
11:30AM 08/19/09
Biotech Calendar: Key Dates and Events
A quick and dirty guide to important biotech events for the busy month of September.
09:00AM 08/18/09
Baytex, Chubb, Gentiv: Ratings Changes
TheStreet.com Ratings has upgraded Baytex Energy Trust, Chubb and Gentiva Health Services.
01:00AM 08/14/09



Connect with TheStreet